Astra Buying Bristol Makes No Sense, Fazeli Says

AstraZeneca shares plunged Monday on news that the drugmaker was exploring an acquisition of Bristol Meyers Squibb. A deal would create one of the world's biggest drugmakers. Sam Fazeli of Bloomberg Intelligence says a takeover would make no sense. (Source: Bloomberg)
Read Full Article at Bloomberg ↗ ← Back to Feed